Overview

A Study of Ketamine in Patients With Treatment-resistant Depression

Status:
Completed
Trial end date:
2013-09-12
Target enrollment:
Participant gender:
Summary
The purpose of this study is to explore the optimal dose frequency of ketamine in patients with treatment-resistant depression (TRD).
Phase:
Phase 2
Details
Lead Sponsor:
Janssen Research & Development, LLC
Treatments:
Ketamine